Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Blocking/Neutralizing [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB2471-100 - Provider product page
- Provider
- R&D Systems
- Product name
- Human IL-15 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from ascites. Detects human IL-15 in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human (rh) IL-2, recombinant mouse IL-15, or rhIL-21 is observed.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Antigen sequence
P40933
- Isotype
- IgG
- Antibody clone number
- 34559
- Vial size
- 100 ug
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Submitted references Human central nervous system astrocytes support survival and activation of B cells: implications for MS pathogenesis.
MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling.
A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions.
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.
Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus.
IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers.
Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.
Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines.
Touil H, Kobert A, Lebeurrier N, Rieger A, Saikali P, Lambert C, Fawaz L, Moore CS, Prat A, Gommerman J, Antel JP, Itoyama Y, Nakashima I, Bar-Or A, Canadian B Cell Team in MS.
Journal of neuroinflammation 2018 Apr 19;15(1):114
Journal of neuroinflammation 2018 Apr 19;15(1):114
MiR-205/YAP1 in Activated Fibroblasts of Breast Tumor Promotes VEGF-independent Angiogenesis through STAT3 Signaling.
Du YE, Tu G, Yang G, Li G, Yang D, Lang L, Xi L, Sun K, Chen Y, Shu K, Liao H, Liu M, Hou Y
Theranostics 2017;7(16):3972-3988
Theranostics 2017;7(16):3972-3988
A Refractory Celiac Patient Successfully Treated With Mesenchymal Stem Cell Infusions.
Ciccocioppo R, Gallia A, Avanzini MA, Betti E, Picone C, Vanoli A, Paganini C, Biagi F, Maccario R, Corazza GR
Mayo Clinic proceedings 2016 Jun;91(6):812-9
Mayo Clinic proceedings 2016 Jun;91(6):812-9
Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner.
Anguille S, Van Acker HH, Van den Bergh J, Willemen Y, Goossens H, Van Tendeloo VF, Smits EL, Berneman ZN, Lion E
PloS one 2015;10(5):e0123340
PloS one 2015;10(5):e0123340
Type I IFNs and IL-18 regulate the antiviral response of primary human γδ T cells against dendritic cells infected with Dengue virus.
Tsai CY, Liong KH, Gunalan MG, Li N, Lim DS, Fisher DA, MacAry PA, Leo YS, Wong SC, Puan KJ, Wong SB
Journal of immunology (Baltimore, Md. : 1950) 2015 Apr 15;194(8):3890-900
Journal of immunology (Baltimore, Md. : 1950) 2015 Apr 15;194(8):3890-900
IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers.
Marra P, Mathew S, Grigoriadis A, Wu Y, Kyle-Cezar F, Watkins J, Rashid M, De Rinaldis E, Hessey S, Gazinska P, Hayday A, Tutt A
Cancer research 2014 Sep 1;74(17):4908-21
Cancer research 2014 Sep 1;74(17):4908-21
Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection.
Muntasell A, Magri G, Pende D, Angulo A, López-Botet M
Blood 2010 Jun 24;115(25):5170-9
Blood 2010 Jun 24;115(25):5170-9
Juxtacrine function of interleukin-15/interleukin-15 receptor system in tumour derived human B-cell lines.
Tsukamoto K, Huang YC, Dorsey WC, Carns B, Sharma V
Clinical and experimental immunology 2006 Dec;146(3):559-66
Clinical and experimental immunology 2006 Dec;146(3):559-66
No comments: Submit comment
Supportive validation
- Submitted by
- R&D Systems (provider)
- Main image
- Experimental details
- Cell Proliferation Induced by IL-15 and Neutralization by Human IL-15 Antibody. Recombinant Human IL-15 (Catalog # 247-ILB) stimulates proliferation in the MO7e human megakaryocytic leukemic cell line in a dose-dependent manner (orange line), as measured by Resazurin (Catalog # AR002). Proliferation elicited by Recombinant Human IL-15 (5 ng/mL) is neutralized (green line) by increasing concentrations of Mouse Anti-Human IL-15 Monoclonal Antibody (Catalog # MAB2471). The ND50 is typically 0.1-0.5 µg/mL.